News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,329 Results
Type
Article (85599)
Company Profile (744)
Press Release (744986)
Section
Business (232251)
Career Advice (4103)
Deals (39644)
Drug Delivery (116)
Drug Development (90653)
Employer Resources (194)
FDA (17976)
Job Trends (17271)
News (395574)
Policy (39617)
Tag
Academia (2975)
Alliances (56439)
Alzheimer's disease (1333)
Approvals (17881)
Artificial intelligence (154)
Bankruptcy (394)
Best Places to Work (12518)
Biotechnology (509)
Breast cancer (128)
Cancer (1152)
Cardiovascular disease (109)
Career advice (3511)
Cell therapy (267)
Clinical research (71488)
Collaboration (405)
Compensation (200)
COVID-19 (2802)
C-suite (103)
Data (1129)
Diabetes (168)
Diagnostics (6676)
Earnings (94741)
Employer resources (167)
Events (126718)
Executive appointments (307)
FDA (18519)
Funding (361)
Gene therapy (200)
GLP-1 (693)
Government (5045)
Healthcare (20711)
Infectious disease (2893)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17582)
Job creations (5178)
Job search strategy (2854)
Layoffs (489)
Legal (10043)
Lung cancer (188)
Manufacturing (198)
Medical device (14411)
Medtech (14416)
Mergers & acquisitions (22094)
Metabolic disorders (467)
Neuroscience (1627)
NextGen Class of 2024 (7657)
Non-profit (5063)
Northern California (1487)
Obesity (266)
Opinion (243)
Patents (109)
People (64137)
Pharmaceutical (147)
Phase I (21992)
Phase II (31044)
Phase III (23408)
Pipeline (462)
Postmarket research (3539)
Preclinical (9946)
Radiopharmaceuticals (257)
Rare diseases (241)
Real estate (7372)
Regulatory (25947)
Research institute (2641)
Resumes & cover letters (648)
Southern California (1319)
Startups (4275)
United States (14344)
Vaccines (651)
Weight loss (219)
Date
Today (161)
Last 7 days (1009)
Last 30 days (3949)
Last 365 days (38435)
2024 (34997)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (227)
Asia (49325)
Australia (8692)
California (3453)
Canada (1289)
China (258)
Colorado (154)
Connecticut (165)
Europe (112979)
Florida (456)
Georgia (125)
Illinois (414)
Indiana (213)
Kansas (103)
Maryland (624)
Massachusetts (2813)
Michigan (173)
Minnesota (294)
New Jersey (985)
New York (977)
North Carolina (836)
Northern California (1487)
Ohio (145)
Pennsylvania (858)
South America (1647)
Southern California (1319)
Texas (492)
Washington State (394)
There are 831,329 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eyes Second Phase III
After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB are planning a second late-stage trial by the end of the year to support a drug application.
November 19, 2024
·
3 min read
·
Tristan Manalac
Cell Therapy
CAR T for Lupus Takes Center Stage at ACR 2024
Investigational CAR T therapies stole the spotlight at the American College of Rheumatology Convergence as data presented by Bristol Myers Squibb, Kyverna Therapeutics and more highlighted their potential to effectively treat lupus.
November 19, 2024
·
4 min read
·
Kate Goodwin
Drug Development
ATTR-CM Approval for BridgeBio Could Trigger Tight Race with Pfizer
Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than Pfizer’s already established tafamidis.
November 19, 2024
·
6 min read
·
Heather McKenzie
Pipeline
Neurogene Drops Batten Gene Therapy Program in Second Blow This Week
After failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells investors that it’s evaluating options for the program.
November 19, 2024
·
2 min read
·
Kate Goodwin
Clinical research
Merck’s Subcutaneous Keytruda Meets Expectations in Phase III
Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster goes off patent in 2028.
November 19, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Quris-AI’s Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation
November 19, 2024
·
1 min read
Press Releases
Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON)
November 19, 2024
·
5 min read
Press Releases
In-Vitro Diagnostics Enzymes Market Size to Surpass USD 4.10 Bn by 2033
November 19, 2024
·
1 min read
Press Releases
Tissue Expanders Market Size Expected to Reach USD 1,309.69 Million by 2034
November 19, 2024
·
1 min read
Press Releases
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
--Six sites across the U.S. are now engaged in Phase1b study
November 19, 2024
·
5 min read
1 of 83,133
Next
